The S&P 500 was up 0.4% in midday trading to 2,843.40.
The Dow Jones Industrial Average rose 0.4% to 26,005.71.
The Nasdaq increased 0.3% to 7,734.05.
The yield on a 10-year Treasury bond was up 0.4% to 2.6%.
The price of gold rose 0.4% to $1,306.
The price of oil fell 0.4% to $58.87 a barrel.
HEALTHCARE
Newport Beach-based Evolus Inc. (Nasdaq: EOLS) surged 12% to $26.67 for a $727 million market cap. Shares in the aesthetics company are trading at more than double their daily average in the first session after the company reported fourth quarter financials and said it expects to launch within a few weeks Jeuveau, a cheaper version of Allergan PLC’s Botox.
Urovant Sciences Ltd. (Nasdaq: UROV) plummeted 18% to $11.39 and a $345 million market cap. The Irvine-based clinical stage biopharma company today reported its drug vibegron failed to clearly outperform a generic.
